Literature DB >> 10577965

Detection of anti-ADAM 10 antibody in serum of a patient with pulmonary fibrosis associated with dermatomyositis.

J Fujita1, T Takeuchi, N Dobashi, Y Ohtsuki, M Tokuda, J Takahara.   

Abstract

OBJECTIVES: It has been suggested that the humoral immune system plays a part in the pathogenesis of pulmonary fibrosis. Although circulating autoantibodies to lung protein(s) have been suggested, few lung proteins have been characterised. The purpose of this study is to determine the antigen recognised by serum of a patient with pulmonary fibrosis associated with dermatomyositis.
METHODS: To accomplish this, anti-small airway epithelial cell (SAEC) antibody in a patient's serum was evaluated using a western immunoblot.
RESULTS: An autoantibody against SAEC was found, and the antigen had a molecular weight of 62 kDa. Using the patient's serum, clones from the normal lung cDNA library were screened and demonstrated that anti-SAEC antibody in the patient's serum was against ADAM (A disintegrin and metalloprotease) 10.
CONCLUSION: This is the first report that demonstrates the existence of anti-ADAM 10 antibody in a patient with pulmonary fibrosis associated with dermatomyositis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577965      PMCID: PMC1752819          DOI: 10.1136/ard.58.12.770

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Idiopathic pulmonary fibrosis is associated with circulating antiepithelial antibodies.

Authors:  Ahmed Fahim; Mei C Chong; Michael G Crooks; Simon P Hart
Journal:  Lung       Date:  2012-05-16       Impact factor: 2.584

2.  Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells.

Authors:  Dominic T Keating; Denise M Sadlier; Andrea Patricelli; Sinead M Smith; Dermot Walls; Jim J Egan; Peter P Doran
Journal:  Respir Res       Date:  2006-09-01

3.  Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease.

Authors:  N I Daffa; P J Tighe; J M Corne; L C Fairclough; I Todd
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

4.  Expression profiling of genes regulated by Fra-1/AP-1 transcription factor during bleomycin-induced pulmonary fibrosis.

Authors:  Subbiah Rajasekaran; Narsa M Reddy; Wei Zhang; Sekhar P Reddy
Journal:  BMC Genomics       Date:  2013-06-07       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.